Back
29
Day Range
$2.19
$2.19
52-Week Range
$2.14
$3.30
Volume
100
50D / 200D Avg
$2.70
/
$2.73
Prev Close
$2.19
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 32.1 | 0.4 |
| P/B | 3.2 | 2.9 |
| ROE % | 10.6 | 3.7 |
| Net Margin % | 10.4 | 3.8 |
| Rev Growth 5Y % | 18.2 | 10.0 |
| D/E | 0.0 | 0.2 |
Key Takeaways
Revenue grew 18.22% annually over 5 years — strong growth
Earnings grew 59.39% over the past year
ROE of 10.55% — decent returns on equity
Debt/Equity of 0.04 — conservative balance sheet
Generating 35.26M in free cash flow
P/E of 32.13 — premium valuation
Growth
Revenue Growth (5Y)
18.22%
Revenue (1Y)17.01%
Earnings (1Y)59.39%
FCF Growth (3Y)33.64%
Quality
Return on Equity
10.55%
ROIC3.08%
Net Margin10.39%
Op. Margin4.49%
Safety
Debt / Equity
0.04
Current Ratio5.66
Interest Coverage6.10
Valuation
P/E Ratio
32.13
P/B Ratio3.16
EV/EBITDA57.22
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 17.01% | Revenue Growth (3Y) | 8.97% |
| Earnings Growth (1Y) | 59.39% | Earnings Growth (3Y) | 1.97% |
| Revenue Growth (5Y) | 18.22% | Earnings Growth (5Y) | 24.60% |
| Profitability | |||
| Revenue (TTM) | 198.93M | Net Income (TTM) | 20.68M |
| ROE | 10.55% | ROA | 7.59% |
| Gross Margin | 78.25% | Operating Margin | 4.49% |
| Net Margin | 10.39% | Free Cash Flow (TTM) | 35.26M |
| ROIC | 3.08% | FCF Growth (3Y) | 33.64% |
| Safety | |||
| Debt / Equity | 0.04 | Current Ratio | 5.66 |
| Interest Coverage | 6.10 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 32.13 | P/B Ratio | 3.16 |
| P/S Ratio | 3.34 | PEG Ratio | 0.84 |
| EV/EBITDA | 57.22 | Dividend Yield | 0.00% |
| Market Cap | 664.33M | Enterprise Value | 510.72M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 198.93M | 170.01M | 167.52M | 119.73M | 101.83M |
| Net Income | 20.68M | 12.97M | 19.88M | 3.74M | 8.58M |
| EPS (Diluted) | 0.07 | 0.04 | 0.06 | 0.01 | 0.03 |
| Gross Profit | 155.66M | 132.44M | 125.66M | 86.15M | 74.91M |
| Operating Income | 8.93M | 9.12M | 18.00M | 792,000.0 | 8.38M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 272.48M | 237.34M | 226.08M | 193.24M | 164.58M |
| Total Liabilities | 62.57M | 55.14M | 62.22M | 54.55M | 29.01M |
| Shareholders' Equity | 209.91M | 182.20M | 163.86M | 138.69M | 135.57M |
| Total Debt | 7.69M | 9.30M | 10.72M | 11.71M | 2.49M |
| Cash & Equivalents | 161.29M | 129.55M | 112.16M | 94.51M | 96.03M |
| Current Assets | 225.32M | 198.45M | 181.24M | 150.50M | 142.15M |
| Current Liabilities | 39.79M | 32.23M | 33.03M | 28.64M | 19.54M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#840 of 1024
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026